HIMS

$33.25-$0.58 (-1.73%)live

Held · Bookmarked

0 · 0

portfolios · users

Platform exposure

13F filers

2

institutions

Market cap

$7.6B

231M shares

52-week range

$13.74 – $70.43

34% from low

Sector

SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE

Exchange

NYSE

CS

Borrow rate

0.50%

Easy to borrow

Price (6 mo)

Loading chart…
Change+$22.31

Hims & Hers Health, Inc.

Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.

www.forhims.com
Employees
2,442
IPO / List date
Jan 21, 2021
HQ
SAN FRANCISCO, CA

Held by traders on TradeandTell

No one on the platform currently holds HIMS.

Super investors & insiders

Institutions holding (13F)
InstitutionSharesReported
Renaissance Technologiesas of 2025-09-309,096,852$516.0M
Bridgewater Associatesas of 2026-03-3141,562$862.8K
Insider activity (SEC Form 4)

Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.

Recent trades on TradeandTell

No one on the platform has traded HIMS yet.

$HIMS chatter on StockTwits

  • Ken@Kenan123Bullish2h

    $ADUR $HIMS

    View on StockTwits ↗
  • Peer Tersch@PeeeerBearish4h

    $HIMS 😶‍🌫️

    View on StockTwits ↗
  • Michael Anthony@myman1956Bearish9h

    $HIMS Back down to $22.00 by CEO comments and other insiders selling like1999 and CEO selling.

    View on StockTwits ↗
  • Bob Kronemyer@inquisitive1Bullish9h

    $HIMS I don't think it's the end of the world for HIMS, if we trade between $33 and $36 over the next two weeks, before another leg up.

    View on StockTwits ↗
  • Lt.Opus@MorganChaseBullish9h

    $HIMS 🤯🤯🤯💵💵💵💵💵

    View on StockTwits ↗
  • Elizabeth Hartford@CapitalTitan9h

    $HIMS $ESTC $ADBE $BB is trading in a way that reflects AI momentum continuation. I am staying disciplined and letting the chart confirm the narrative.

    View on StockTwits ↗
  • Gary McIlvaine@Bigg554Bullish10h

    $HIMS I’ve used the Wolverine peptide blend. It works. I invested in this because peptides are the future of preventative medicine. Stanford’s Andrew Huenermann already called them out! The meeting is in a month. I imagine the price action leading up is going to be epic. If it’s sell the news when they decide that means the next few weeks will see a massive run up in price. Regardless I’m in for the long haul tint this next month is going to be fun to watch!

    View on StockTwits ↗
  • Woll Schv@IdioSyncro10h

    $HIMS did hims open up their peptide factory yet? Will it be 2030 when they get FDA approval?

    View on StockTwits ↗
  • Kevin Hoffman@Panopticon202410h

    $QS 22.4M volume. That is huge. Compare to $HIMS $PL $SOFI other popular retail squeeze names. This is ready to explode.

    View on StockTwits ↗
  • Tyler joles@RooksteadyBearish11h

    $aplD followed @professorpump over here...going to try and show him how to make some money off this pipe dream...still a. $HIMS hater though...we watching to see if there's one more pump out there before bleeding into surprise crappy earnings..

    View on StockTwits ↗
  • Althea Hardter@AIInvestorr11h

    My position in $DKNG $HIMS $ADBE is based on liquidity rotation setup. Volatility is expected, but the structure still looks intact.

    View on StockTwits ↗
  • AXLFI_HQ@AXLFI_HQ11h

    $HIMS Telehealth platforms are capturing accelerating growth in weight-loss and peptide therapeutics, with FDA regulatory decisions creating binary outcomes for market sizing and competitive positioning. Learn more: https://axlfi.com/themes/380

    View on StockTwits ↗
  • Renee Dean@BullNavigatorr12h

    My position in $HIMS $GLXY is based on macro sentiment shift. Volatility is expected, but the structure still looks intact.

    View on StockTwits ↗
  • Chris@isEEu2812h

    $HIMS $NBIS $OSCR $TE $ZETA

    View on StockTwits ↗
  • Drip Drip@Drip10112h

    @CosmicMiner That chart looks like $HIMS chart back when I bought in the summer/fall 2024. Might have to sell some over $30 and buy back at $19.

    View on StockTwits ↗

Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.